Bilateral Meetings
- Thursday (1:30pm – 6:00pm)
- Friday (9:00am – 12:00pm)
- Friday (12:00pm – 4:00pm)
.png){kind=logo}
A UK-based SME is offering the services of its network of over 70 consultants, each with an average of 20 years' experience in the drug discovery field. This expertise covers therapeutic areas including cardiovascular and metabolic diseases, respiratory, inflammation, immunology, virology, dermatology, pain, oncology, central nervous system conditions and rare & orphan diseases. This expertise also covers a wide range of molecule classes from small molecules to biologics.
These experts can provide tailored support to partners to help them overcome challenges in their drug development projects that are presenting barriers to getting these new agents to market. They offer a flexible approach used to ensure an optimal team is configured to meet project needs, to define the most cost-effective strategy to progress the project and then rapidly implement this strategy. This can range from technical advice and designing key studies to data processing and logistics. This support can cover the drug development process from discovery, development and preclinical to the initiation of the clinical trial process.
The SME is looking to partner with companies, universities and research institutions working in drug discovery and development, to help them overcome the individual challenges of their projects. It is envisaged that these partnerships will take the form of services agreements.
Drug discovery services and Expertise
Drug discovery and development is a time consuming and often complicated process that requires in-depth and multidisciplinary expertise in order to ensure that the right strategy is adopted to generate the robust data required to reach market while avoiding duplication of effort and unnecessary work. Companies working in the field of drug discovery do not always have this level of expertise in-house, especially in the case of development of active agents for rare and orphan indications. This lack of access to the relevant expertise can slow the development process and may prevent new actives reaching the market.
A UK-based SME is offering the services of its network of over 70 consultants, each with an average of 20 years' experience in the drug discovery field. This expertise covers therapeutic areas including cardiovascular and metabolic diseases, respiratory, inflammation, immunology, virology, dermatology, pain, oncology, central nervous system conditions and rare & orphan diseases. This expertise also covers a wide range of molecule classes from small molecules to biologics.
These experts can provide tailored support to partners to help them overcome challenges in their drug development projects that are presenting barriers to getting these new agents to market. They offer a flexible approach used to ensure an optimal team is
configured to meet project needs, to define the most cost-effective strategy to progress the project and then rapidly implement this strategy. This can range from technical advice and designing key studies to data processing and logistics. This support can cover the drug development process from discovery, development and preclinical to the initiation of the clinical trial process.
The SME is looking to partner with companies, universities and research institutions working in drug discovery and development, to help them overcome the individual challenges of their projects. It is envisaged that these partnerships will take the form of services agreements.
- Outsourcing co-operation
- Technical co-operation
- License agreement
- Investment/Financing
- Outsourcing co-operation
- Technical co-operation
- License agreement
- Investment/Financing
Biological screening services and support
The Biological Pharmacology Team is a group of drug discovery experts who specialise ensuring molecules progress from project initiation to the pre-clinic studies effectively and efficiently. Our expertise focuses on ensuring that your screening cascades are underpinned by sound pharmacological principles and propelled by cutting-edge technology and assay paradigms. We have developed innovative screening approaches and analytical methodologies to triage your active compounds for differentiating, advantageous pharmacology profiles and mechanisms of action.
With experience of working across the pharmaceutical industry the team can make even the most challenging targets tractable. The team have worked across many target classes, including enzymes, GPCRs and ion channels and have experience in numerous therapeutic areas including, oncology, neuroscience, respiratory disease and immunology.
- Technical co-operation
- Outsourcing co-operation
- Technical co-operation